TG Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
20.56
|
|
Average Rating
|
4.11
|
|
# Strong Buys
|
5
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
2
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.34
|
-0.26
|
0.08
|
23.53%
|
|
2022-06-30
|
-0.51
|
-0.30
|
0.21
|
41.18%
|
|
2022-03-31
|
-0.59
|
-0.51
|
0.08
|
13.56%
|
|
2021-12-31
|
-0.63
|
-0.70
|
-0.07
|
-11.11%
|
|
2021-09-30
|
-0.56
|
-0.65
|
-0.09
|
-16.07%
|
|
2021-06-30
|
-0.50
|
-0.59
|
-0.09
|
-18.00%
|
|
2021-03-31
|
-0.49
|
-0.69
|
-0.20
|
-40.82%
|
|
2020-12-31
|
-0.58
|
-0.71
|
-0.13
|
-22.41%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.07
|
|
2021-12-31
|
-2.63
|
|
2020-12-31
|
-2.39
|
|
2019-12-31
|
-1.98
|
|
2018-12-31
|
-2.30
|
|
2017-12-31
|
-1.91
|
|
2016-12-31
|
-1.59
|
|
2015-12-31
|
-1.42
|
|
2014-12-31
|
-1.56
|
|
2013-12-31
|
-0.81
|
|
2012-12-31
|
8.44
|
|
2010-12-31
|
-0.92
|
|
2009-12-31
|
-111.24
|
|
2008-12-31
|
-2056.95
|
|
2004-12-31
|
-687.52
|
|
2003-12-31
|
-801.74
|
|
2002-12-31
|
-1342.66
|
|
2001-12-31
|
-4684.21
|
|
2000-12-31
|
-17650.46
|
|
1999-12-31
|
-8252.99
|
|
1998-12-31
|
-18361.89
|